RedHill Biopharma to Host Fourth Quarter and Full
Post# of 111
(Total Views: 297)
Posted On: 03/13/2022 2:04:14 PM
RedHill Biopharma to Host Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights Webcast on March 17, 2022
TEL AVIV, Israel and RALEIGH, NC, March 10, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"
, a specialty biopharmaceutical company, today announced that it will report its fourth quarter and full year 2021 financial results and operational highlights on Thursday, March 17, 2022.
The Company will host a conference call and webcast on Thursday, March 17, 2022, at 8:30 a.m. EDT, during which it will present key highlights for the fourth quarter and full year of 2021.
The webcast including slides will be broadcast live on the Company's website, https://ir.redhillbio.com/events , and will be available for replay for 30 days.
To participate in the conference call, please dial one of the following numbers 15 minutes prior to the start of the call: United States: +1-877-870-9135 ; International: +1-646-741-3167; and Israel: +972-3-530-8845; the access code for the call is: 2368401.
TEL AVIV, Israel and RALEIGH, NC, March 10, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"
, a specialty biopharmaceutical company, today announced that it will report its fourth quarter and full year 2021 financial results and operational highlights on Thursday, March 17, 2022. The Company will host a conference call and webcast on Thursday, March 17, 2022, at 8:30 a.m. EDT, during which it will present key highlights for the fourth quarter and full year of 2021.
The webcast including slides will be broadcast live on the Company's website, https://ir.redhillbio.com/events , and will be available for replay for 30 days.
To participate in the conference call, please dial one of the following numbers 15 minutes prior to the start of the call: United States: +1-877-870-9135 ; International: +1-646-741-3167; and Israel: +972-3-530-8845; the access code for the call is: 2368401.
(0)
(0)Redhill Biopharma Ltd. (RDHL) Stock Research Links
Scroll down for more posts ▼